510(k) Report

510(k) · Cleared

Cleared

Detlogix Annuloplasty Ring, Model: 5100

K083191510(k) TraditionalCleared Apr 10, 2009163-day reviewClass II21 CFR 870.3800

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Edwards Lifesciences, LLC · KRH Ring, Annuloplasty

Cleared on Apr 10, 2009 as substantially equivalent to K032250 (Edwards Lifesciences, LLC, 2003) and 2 other predicates after a 163-day review. Its family tree reaches back 3 generations to 1993.

Decided
Apr 10, 2009
Review
163 days
Class
Class II
Product code
KRH
Recalls
None
Predicates
3

Its longest line of descent runs back 3 generations to K923367 (1993). 5 ancestors in all, the oldest K831949 (1983). No later device cites it as a predicate yet.

  1. Root · 3 generations backK923367 Cosgrove Edwards Annuloplasty System, Model 4600Baxter Healthcare Corp · 1993
  2. 2 generations backK020864 Edwards MC Tricuspid Annuloplasty System, Model 4900Edwards Lifesciences, LLC · 2002
  3. 1 generation backK032250 Geoform Annuloplasty Ring, Mitral Model 4200Edwards Lifesciences, LLC · 2003
  4. This deviceK083191 Detlogix Annuloplasty Ring, Model: 5100Edwards Lifesciences, LLC · 2009
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K923367Cosgrove Edwards Annuloplasty System, Model 4600Baxter Healthcare Corp1993—
−2K020864Edwards MC Tricuspid Annuloplasty System, Model 4900Edwards Lifesciences, LLC2002—
−1K032250Geoform Annuloplasty Ring, Mitral Model 4200Edwards Lifesciences, LLC2003—
0 (this device)K083191Detlogix Annuloplasty Ring, Model: 5100Edwards Lifesciences, LLC2009—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198310
199310
FIG. 1 — Lineage of K083191, 1993–2009Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in KRH? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new KRH device

  1. #1 K261707 MEMO 4D Curve™ Semirigid mitral annuloplasty…score 12.7 · 5 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (3)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K032250Geoform Annuloplasty Ring, Mitral Model 4200
Summary page 1
…Tlog iXT m annuloplasty ring Classification Name: Class II,CFR 870.3800 Annuloplasty Ring, KRH Predicate Device(s): CeoForm® annuloplasty ring (K032250) Carpentier-Edwards Physio® annuloplasty ring (K9261 38)…
Edwards Lifesciences, LLC2003—
*K926138Carpentier-Edwards Physio Annuloplasty Ring
Summary page 1
…e(s): CeoForm® annuloplasty ring (K032250) Carpentier-Edwards Physio® annuloplasty ring (K9261 38) Carpentier-Edwards Classico annuloplasty ring (K831 949) Dev…
Baxter Healthcare Corp1993—
*K831949Prosthetic Rings #4400 Mitral & 4500
Summary page 1
…asty ring (K9261 38) Carpentier-Edwards Classico annuloplasty ring (K831 949) Device Description: The dETlogiXTm annuloplasty ring, model 5100, is constructed…
American Edwards Laboratories1983—

Also cleared against K032250: 2 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 16 years and passes through 2 companies; a new generation was cleared every 5.6 years on median.
  • None of the 5 ancestors has a recall.
  • 2 other devices also cite its predicate K032250.

How does its category compare?

All KRH devices

KRH Ring, Annuloplasty: FDA decisions, review times, recalls and adverse event reports over 20 years. 2009, this device’s year, is highlighted.

FDA decisions per year · KRH

4in 2025

2007: 42008: 22009: 82010: 22011: 22014: 12016: 12018: 22019: 22020: 22023: 22024: 12025: 42026 (partial year): 2
2007high 8 (2009) · low 0 (2012)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · KRH

98in 2025

2007: 90 days median2009: 68 days median2025: 98 days median
2007high 98 (2025) · low 68 (2009)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · KRH

No recall names KRH since 2007.

Adverse event reports per year · KRH

420in 2025

2007: 2612008: 1,2882009: 9732010: 6302011: 3212012: 902013: 972014: 732015: 1452016: 3472017: 3792018: 3782019: 3492020: 3402021: 4232022: 3722023: 3242024: 4072025: 420
2007high 1,288 (2008) · low 73 (2014)2025

MAUDE reports naming product code KRH, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20074900261
20082—01,288
20098680973
20102—0630
20112—0321
20120—090
20130—097
20141—073
20150—0145
20161—0347
20170—0379
20182—0378
20192—0349
20202—0340
20210—0423
20220—0372
20232—0324
20241—0407
20254980420
20262—0—

What is it indicated for?

The dETIogix annuloplasty ring, model 51 00, is indicated for the correction of mitral valvular insufficiency where the lesions are not severe enough as to require total valve replacement. The decision to undertake valvuloplasty can be made only after visual analysis of the lesion present. The most favorable conditions for valvuloplasty using an annuloplasty ring are a combination of a distended natural valve ring associated with supple valve cusps and…

Read the full statement (170 words)

The dETIogix annuloplasty ring, model 51 00, is indicated for the correction of mitral valvular insufficiency where the lesions are not severe enough as to require total valve replacement.

The decision to undertake valvuloplasty can be made only after visual analysis of the lesion present. The most favorable conditions for valvuloplasty using an annuloplasty ring are a combination of a distended natural valve ring associated with supple valve cusps and normal chordae tendineae.

The remodeling valvuloplasty technique with a prosthetic ring may be used in all acquired or congenital mitral insufficiencies with dilatation and deformation of the fibrous mitral annulus.

For Type I mitral insufficiencies with no subvalvular lesions and normal valvular movements, this ring technique used alone is sufficient. However, the ring technique must be associated with mitral valvuloplasty repair in Type II insufficiencies with a prolapsed valve due to elongation or rupture of the chordae tendineae and in Type III insufficiencies with limitation of valvular movements due to fusion of the commissures or chordae tendineae, or chordal hypertrophy.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K083191: Detlogix Annuloplasty Ring, Model: 5100.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 3, 2026. https://510kreport.com/device/K083191

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026